254 related articles for article (PubMed ID: 37588264)
1. Adding a Chemical Biology Twist to CRISPR Screening.
Huang S; Baskin JM
Isr J Chem; 2023 Feb; 63(1-2):. PubMed ID: 37588264
[TBL] [Abstract][Full Text] [Related]
2. New Developments in CRISPR/Cas-based Functional Genomics and their Implications for Research Using Zebrafish.
Prykhozhij SV; Caceres L; Berman JN
Curr Gene Ther; 2017; 17(4):286-300. PubMed ID: 29173171
[TBL] [Abstract][Full Text] [Related]
3. Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening.
Sun N; Petiwala S; Wang R; Lu C; Hu M; Ghosh S; Hao Y; Miller CP; Chung N
BMC Genomics; 2019 Mar; 20(1):225. PubMed ID: 30890156
[TBL] [Abstract][Full Text] [Related]
4. Scalable CRISPR-Cas9 chemical genetic screens in non-transformed human cells.
Lin K; Chang YC; Marron Fernandez de Velasco E; Wickman K; Myers CL; Bielinsky AK
STAR Protoc; 2022 Dec; 3(4):101675. PubMed ID: 36107744
[TBL] [Abstract][Full Text] [Related]
5. Pooled CRISPR Screens in Drosophila Cells.
Viswanatha R; Brathwaite R; Hu Y; Li Z; Rodiger J; Merckaert P; Chung V; Mohr SE; Perrimon N
Curr Protoc Mol Biol; 2019 Dec; 129(1):e111. PubMed ID: 31763777
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas9 Toolkit for Genome Editing in an Autotrophic CO
Li J; Zhang L; Xu Q; Zhang W; Li Z; Chen L; Dong X
Microbiol Spectr; 2022 Aug; 10(4):e0116522. PubMed ID: 35766512
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Based Lentiviral Knockout Libraries for Functional Genomic Screening and Identification of Phenotype-Related Genes.
Thomsen EA; Mikkelsen JG
Methods Mol Biol; 2019; 1961():343-357. PubMed ID: 30912056
[TBL] [Abstract][Full Text] [Related]
8. Identifying synthetic lethal targets using CRISPR/Cas9 system.
Dhanjal JK; Radhakrishnan N; Sundar D
Methods; 2017 Dec; 131():66-73. PubMed ID: 28710008
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9-mediated gene knockout screens and target identification via whole-genome sequencing uncover host genes required for picornavirus infection.
Kim HS; Lee K; Bae S; Park J; Lee CK; Kim M; Kim E; Kim M; Kim S; Kim C; Kim JS
J Biol Chem; 2017 Jun; 292(25):10664-10671. PubMed ID: 28446605
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas-based customization of pooled CRISPR libraries.
Kweon J; Kim DE; Jang AH; Kim Y
PLoS One; 2018; 13(6):e0199473. PubMed ID: 29924860
[TBL] [Abstract][Full Text] [Related]
11. Tissue-Specific CRISPR-Cas9 Screening in Drosophila.
Port F; Boutros M
Methods Mol Biol; 2022; 2540():157-176. PubMed ID: 35980577
[TBL] [Abstract][Full Text] [Related]
12. CRISPR screening in hematology research: from bulk to single-cell level.
Meyers S; Demeyer S; Cools J
J Hematol Oncol; 2023 Oct; 16(1):107. PubMed ID: 37875911
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide CRISPR-Cas9 screening in mammalian cells.
Yu JSL; Yusa K
Methods; 2019 Jul; 164-165():29-35. PubMed ID: 31034882
[TBL] [Abstract][Full Text] [Related]
14. Chemical-genetic CRISPR-Cas9 screens in human cells using a pathway-specific library.
Hundley FV; Toczyski DP
STAR Protoc; 2021 Sep; 2(3):100685. PubMed ID: 34382013
[TBL] [Abstract][Full Text] [Related]
15. Identification of Drug Resistance Genes Using a Pooled Lentiviral CRISPR/Cas9 Screening Approach.
Kerek EM; Cromwell CR; Hubbard BP
Methods Mol Biol; 2021; 2381():227-242. PubMed ID: 34590280
[TBL] [Abstract][Full Text] [Related]
16. SliceIt: A genome-wide resource and visualization tool to design CRISPR/Cas9 screens for editing protein-RNA interaction sites in the human genome.
Vemuri S; Srivastava R; Mir Q; Hashemikhabir S; Dong XC; Janga SC
Methods; 2020 Jun; 178():104-113. PubMed ID: 31494246
[TBL] [Abstract][Full Text] [Related]
17. High-throughput genetic screens using CRISPR-Cas9 system.
Kweon J; Kim Y
Arch Pharm Res; 2018 Sep; 41(9):875-884. PubMed ID: 29637495
[TBL] [Abstract][Full Text] [Related]
18. GenomeCRISPR - a database for high-throughput CRISPR/Cas9 screens.
Rauscher B; Heigwer F; Breinig M; Winter J; Boutros M
Nucleic Acids Res; 2017 Jan; 45(D1):D679-D686. PubMed ID: 27789686
[TBL] [Abstract][Full Text] [Related]
19. Reduced gene templates for supervised analysis of scale-limited CRISPR-Cas9 fitness screens.
Vinceti A; Perron U; Trastulla L; Iorio F
Cell Rep; 2022 Jul; 40(4):111145. PubMed ID: 35905712
[TBL] [Abstract][Full Text] [Related]
20. High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells.
Steyer B; Carlson-Stevermer J; Angenent-Mari N; Khalil A; Harkness T; Saha K
Acta Biomater; 2016 Apr; 34():143-158. PubMed ID: 26747759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
